Rituximab Demonstrates Potential Efficacy in Treatment of Special Forms of RA
November 8th 2023A retrospective analysis suggested that administering rituximab to patients with rheumatoid arthritis complicated by lymphoma, systemic vasculitis, or extra-articular lesions was associated with improved outcomes.
Read More
Multiple Barriers Impact Kidney Care Disparities in LGBTQ+ Individuals
November 5th 2023Presenters at American Society of Nephrology Kidney Week 2023 highlighted the importance of understanding the barriers faced by the LGBTQ+ community that impact kidney outcomes and the need to gather better data for studying these issues.
Read More
Economic Burden and Predicting Disease Progression of CKD Highlighted at ASN Kidney Week 2023
November 4th 2023Posters at ASN Kidney Week 2023 explored the economic burden brought on by chronic kidney disease (CKD) and further validated the Klinrisk model’s ability to predict progressive forms of CKD.
Read More
Presenters Have Hope for the Future of Trial Design in Pediatric Chronic Kidney Disease
November 3rd 2023Presenters at the American Society of Nephrology's Kidney Week 2023 discussed the past, present, and future of pediatric chronic kidney disease, as well as explored the obstacles and solutions for effective trial designs.
Read More
SPHERE Registry Data Highlight Racial, Ethnic Disparities in PAH Treatment, Outcomes
October 31st 2023Data from the SPHERE registry revealed racial and ethnic discrepancies in disease severity, comorbidities, and outcomes experienced by patients with pulmonary arterial hypertension (PAH) receiving selexipag.
Read More
ASN Kidney Week Returns to Philadelphia to Highlight Latest Innovations, Issues in Renal Care
October 30th 2023The American Society of Nephrology (ASN) Kidney Week 2023 will take place in Philadelphia, Pennsylvania, from November 2-5, as experts from across the globe gather to discuss the latest innovations in renal care and current issues facing the field.
Read More
Patients With RA Are at Increased Risk for Aortic Stenosis, Study Suggests
October 25th 2023Results from a retrospective, matched cohort study suggested that valvular heart disease and aortic stenosis may contribute to disparities in cardiovascular disease–related mortality in patients with rheumatoid arthritis (RA).
Read More
Dr Thomas Powles Discusses Impact of EV+P Therapy on Urothelial Carcinoma Treatment
October 22nd 2023Thomas Powles, MD, MBBS, MRCP, from Barts Cancer Centre, shares insights from the EV-302/KEYNOTE-A39 trial and its implications for the future of enfortumab vedotin and pembrolizumab (EV+P) combination therapy for urothelial carcinoma.
Read More
Dr Kevin Kalinsky Shares Real-World Data on Effects of Sacituzumab Govitecan-hziy in TNBC
October 21st 2023Kevin Kalinsky, MD, MS, of Glenn Family Breast Center, gives insight into the real-world data supporting the use of sacituzumab govitecan-hziy in the treatment of triple-negative breast cancer (TNBC).
Read More
Study Suggests Physical Activity Could Mediate Fatigue in Patients With MS
October 6th 2023Through a multitude of assessment tools, findings suggest that lower amounts of physical activity directly correlate with higher rates of fatigue in patients with relapsing-remitting multiple sclerosis (MS).
Read More